← Back to Search

Wearable Device for Exercise Performance

N/A
Recruiting
Led By Corey Ungaro, PhD
Research Sponsored by PepsiCo Global R&D
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 21-50 years, male and female
Be between 18 and 65 years old
Must not have
If female, not pregnant, planning to get pregnant or currently breastfeeding
Not able to wear wrist-worn device continuously
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline (day1) to mid-study (day 45) and end of study (day 90)
Awards & highlights

Summary

This trial aims to investigate the use of a consumer-grade wearable device (Whoop) to provide personalized training recommendations based on heart rate variability (HRV) in real-world settings. HRV is a

Who is the study for?
This trial is for individuals interested in understanding how their heart rate variability (HRV) relates to exercise performance. Participants should be willing to use a Whoop wrist band and undergo force plate assessments. Specific inclusion or exclusion criteria are not detailed.
What is being tested?
The study aims to explore the connection between HRV, training load, and athletic performance using a Whoop wrist band that measures HRV and other health metrics. It will provide personalized training recommendations based on these measurements.
What are the potential side effects?
Since this trial involves non-invasive monitoring with a wearable device and physical assessments, there are minimal expected side effects. However, typical risks may include discomfort from wearing the device or participating in exercise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 21 and 50 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not pregnant, planning to become pregnant, or breastfeeding.
Select...
I cannot wear a wrist device all the time.
Select...
I am taking prescription medications that affect my sleep.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline (day1) to mid-study (day 45) and end of study (day 90)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline (day1) to mid-study (day 45) and end of study (day 90) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dynamic Push Ups Peak Force
Jump Height
Peak Power Output
+2 more
Secondary outcome measures
Correlation of subjective measures to Heart Rate Variability (HRV)
Correlation of subjective measures to resting heart rate (RHR)
Correlation of subjective measures to sleep efficiency
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single groupExperimental Treatment2 Interventions
Healthy adults moderately trained in resistance exercises

Find a Location

Who is running the clinical trial?

PepsiCo Global R&DLead Sponsor
90 Previous Clinical Trials
12,661 Total Patients Enrolled
Corey Ungaro, PhDPrincipal InvestigatorPepsiCo, Inc. Sports Science
~0 spots leftby Sep 2024